First ever reported cryo-EM visualization of E. coli TGT structure – Phys.org

Researchers have achieved the first cryo-electron microscopy (cryo-EM) visualization of the Escherichia coli threonine glycosyltransferase (TGT) structure, according to a report published by Phys.org on July 22, 2026. This structural mapping allows scientists to see how the enzyme facilitates the attachment of sugars to proteins, a process critical for bacterial survival and pathogenesis.

The study focuses on the TGT enzyme, which is responsible for the glycosylation of proteins in E. coli. Glycosylation is the biochemical process of adding a carbohydrate, or glycan, to a protein. According to the research detailed by Phys.org, this modification affects how bacteria interact with their environment and how they evade the human immune system.

Cryo-EM Technology and the TGT Structure

The team utilized cryo-electron microscopy to capture the TGT structure. Cryo-EM works by flash-freezing biological samples in a thin layer of vitreous ice, preserving their natural state without the need for crystallization. This method allows researchers to observe the enzyme’s architecture at near-atomic resolution.

According to the Phys.org report, the visualization reveals the specific spatial arrangement of the TGT enzyme. By mapping the structure, the researchers identified the active sites where the enzyme binds to its substrates. This level of detail was previously unavailable, as the TGT structure had not been visualized using this technology until this study.

Impact on Bacterial Pathogenesis

The ability of E. coli to modify its surface proteins through TGT-mediated glycosylation is a key factor in its ability to cause infection. These sugar coatings can mask the bacteria from detection by host antibodies and help the bacteria adhere to host tissues.

By understanding the precise shape and function of the TGT enzyme, scientists can better understand how E. coli maintains its virulence. The Phys.org reporting indicates that the structural data provides a blueprint for how the enzyme recognizes and processes its targets within the bacterial cell.

Potential for New Antibiotic Targets

The visualization of the TGT structure offers a potential pathway for developing new antimicrobial treatments. Because glycosylation is essential for the fitness of certain pathogenic strains of E. coli, inhibiting the TGT enzyme could theoretically weaken the bacteria or make them more susceptible to the immune system.

According to the research, the identified active sites on the enzyme can now be targeted for drug design. Small molecules designed to fit into these sites could block the enzyme’s activity, preventing the bacteria from attaching the necessary sugars to their proteins.

This approach targets a specific enzymatic process rather than general bacterial growth, which may reduce the likelihood of broad-spectrum resistance compared to some traditional antibiotics.